Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
US Department of Justice
UBS
Baxter
Moodys
Julphar
Colorcon
Citi

Generated: December 18, 2018

DrugPatentWatch Database Preview

PTAB Cases from IntelGenx Corp

« Back to Dashboard

Patent Trial and Appeal Board Cases for Petitioner: IntelGenx Corp

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,943,166 IntelGenx Corp. ➤ Sign Up 2016-02-26 2016-02-26 Pullman et al Inter partes review ➤ Sign Up 2016-09-01 William Pullman ➤ Sign Up
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Cerilliant
Baxter
Express Scripts
Federal Trade Commission
Accenture
Julphar
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.